2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax PatientsBacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, gram-positive bacterial infections, inhalational anthraxNot yet recruitingNot stated2026-02-06NCT03569553
Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.Bacillaceae infectious disease, Bacterial Infections and Mycoses, Infections, anthrax infection, bacterial infectious disease, cutaneous anthrax, gastrointestinal anthrax, gram-positive bacterial infections, inhalational anthraxNot yet recruitingNot stated2025-12-08NCT07268612